APA (7th ed.) Citation

D, S., A, M., E, N., MS, S., Q, Z., Y, Z., . . . E, L. (2026). ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study. Molecular oncology. https://doi.org/10.1002/1878-0261.70254

Chicago Style (17th ed.) Citation

D, Stergiopoulou, et al. "ESR1 Methylation and ESR1 Mutations in Circulating Tumor Cells (CTCs) and Paired Plasma-cfDNA of Advanced Breast Cancer Patients: A Feasibility Proof-of-concept Study." Molecular Oncology 2026. https://doi.org/10.1002/1878-0261.70254.

MLA (9th ed.) Citation

D, Stergiopoulou, et al. "ESR1 Methylation and ESR1 Mutations in Circulating Tumor Cells (CTCs) and Paired Plasma-cfDNA of Advanced Breast Cancer Patients: A Feasibility Proof-of-concept Study." Molecular Oncology, 2026, https://doi.org/10.1002/1878-0261.70254.